Text Size
1 study found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Carcinoma, Hepatocellular"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: sorafenib tosylate
To Top

† Indicates status has not been verified in more than two years